Navigation Links
Schering-Plough Reports Financial Results for First Quarter of 2008
Date:4/23/2008

25 26 (3%)

Other Pharmaceuticals 708 390 82%

ANIMAL HEALTH b/ 723 232 211%

CONSUMER HEALTH CARE 377 345 9%

OTC 209 177 18%

OTC CLARITIN 139 127 9%

Foot Care 85 78 9%

Sun Care 83 90 (7%)

CONSOLIDATED GAAP NET SALES $4,657 $2,975 56%

a/ Total Human Prescription Pharmaceuticals net sales for the three months

ended March 31, 2008 include net sales of $861 million from Organon,

the human health segment of Organon BioSciences (OBS), which was

acquired on November 19, 2007.

b/ Total Animal Health net sales for the three months ended March 31, 2008

include net sales of $454 million from Intervet, the animal health

segment of OBS, which was acquired on November 19, 2007.

c/ Products acquired in OBS acquisition on November 19, 2007.

NOTE: Additional information about U.S. and international sales for specific products is available by calling the company or visiting the Investor Relations Web site at http://ir.schering-plough.com.

SCHERING-PLOUGH CORPORATION

Reconciliation of Non-U.S. GAAP Financial Measures

Adjusted net sales, defined as net sales plus an assumed 50 percent of global cholesterol joint venture net sales.

(Dollars in millions) Three months ended March 31

(unaudited)

2008 2007 %

Net sales, as reported a/ $4,657 $2
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Schering-Plough Schedules Conference Call and Webcast for 2008 First Quarter Earnings
2. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
3. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
4. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
5. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
6. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
7. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
8. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
9. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
10. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
11. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... PETERSBURG, Russia , July 10, 2014 ... Russian Federation Dmitry Medvedev , presented ... biopharmaceutical company BIOCAD . The Company is developing ... scope of MabNext project BIOCAD develops a number of ... cancer and autoimmune diseases. The ceremony took place at ...
(Date:7/10/2014)... 2014   Ceres, Inc . (Nasdaq: ... today financial results for the three months ended May ... Ceres reported that the company and its ... growing season in Brazil, which concluded in June, despite ... evaluation areas for part of the growing season. Yields ...
(Date:7/10/2014)... the journal PNAS (Proceedings of the National Academy ... and sleep deprivation have a significant effect on our ... the best time of day to test for diseases ... medicines effectively. , Researchers from the University of Surrey ... links between sleep deprivation, body clock disruption and metabolism, ...
(Date:7/10/2014)... forever. Nanophysics makes sure of that. Mechanics researchers at Linkping ... Physical Review E . Knowledge that can be of ... be able to sit still forever, and walk around upside ... soon be able to buy smart new fasteners that hold ... is, sooner or later the grip is lost, no matter ...
Breaking Biology Technology:Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9Time of day crucial to accurately test for diseases, new research finds 2Even geckos can lose their grip 2
... drug discovery and development company eMetagen Corp . ... Marquette University Golden Angels Network , the angel investors ... Golden Angels investment, along with two grants received last ... the National Institutes of Health and a $150,000 Technology ...
... in any foreign land now requires a quick custom check. ... true nationality? What's this nation doing on the global scene ... Do I really like this nation? , ,It's no secret ... savvy than they were a decade ago. They clearly support ...
... - Ann Stunden, director of the Division of ... received a 2005 award for information technology leadership from ... honored Stunden for "strong and ground-breaking leadership in the ... 37 years ago." , ,A co-founder and executive ...
Cached Biology Technology:eMetagen gets $535,000 from MU angel investors 2Why are brands culturally profiled? 2Why are brands culturally profiled? 3
(Date:7/11/2014)... Researchers from Salk Institute for Biological Studies, BGI, ... the safety and reliability of the existing targeted ... method, TALEN-HDAdV, which could significantly increased gene-correction efficiency ... study published online in Cell Stell Cell ... cell-based gene therapy. , The combination of stem ...
(Date:7/11/2014)... 11, 2014 The increased risk of kidney injury ... resuscitation fluids reflects the mass of HES molecules, according ... official journal of the International Anesthesia Research Society (IARS). ... harmful effect of HES on cultured human renal proximal ... Christian Wunder and colleagues of University Hospital Wrzburg, Austria. ...
(Date:7/11/2014)... , July 11, 2014 Research ... "International Biometrics Technology Market - Industry Analysis Size ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... and crimes has created a need for high level ... used for personnel authentication such as username and passwords, ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
... When students using the Ask a Biologist Web site ask ... actually accessing the combined knowledge of more than 150 volunteer ... "That,s why Dr. Biology is so amazing," says Charles Kazilek, ... on the planet." Kazilek,s site, which attracts 3,000-4,000 visitors ...
... for the Advancement of Science has chosen Arizona State ... science education, to receive the Science Prize ... The prize, established to "encourage innovation and excellence in ... resources by students, teachers, and the public," recognizes the ...
... fish species in the ocean, but the majestic gliding ... astonishing feat of mathematics and energy conservation. In new ... Functional Ecology marine scientists reveal how these ... buoyancy and stay afloat. For most animals movement ...
Cached Biology News:Science selects 'Ask a Biologist' website to win SPORE award 2Science selects 'Ask a Biologist' website to win SPORE award 3Science selects 'Ask a Biologist' website to win SPORE award 4ASU’s Ask A Biologist website wins prestigious SPORE prize 2ASU’s Ask A Biologist website wins prestigious SPORE prize 3Whale sharks do the math to avoid that sinking feeling 2
Anti-TNKS2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
Rabbit Anti-Human Janus Kinase 2 (JAK2 Polyclonal Antibody Family: Protein Kinase Sub-Family: TYK2/JAK Applications: ELISA, Western Blot...
Goat polyclonal to Lipocalin 2...
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
Biology Products: